The ratings assignment is based on a number of factors, including CHCC’s large revenue base, good market position and strong clinical services.
Moody’s also affirmed the “Baa1” rating on CHCC’s $534 million of outstanding debt.
The outlook was revised to positive from stable, reflecting Moody’s Investors Service’s expectation CHCC will continue to improve its balance sheet and debt measures, and that its operating measures will remain strong.
More articles on healthcare finance:
Fitch affirms ‘BB’ rating on Marietta Memorial Health System’s bonds
S&P assigns ‘AA-/A-+’ rating to Hospital Sisters Health System’s bonds
Moody’s affirms ‘Aa3’ rating on Partners HealthCare’s bonds
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
